Mediclinic International (Mediclinic International) EBIT per Share : $0.48 (TTM As of Sep. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International EBIT per Share?

Mediclinic International's EBIT per Share for the six months ended in Sep. 2022 was $0.21. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 was $0.48.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Mediclinic International's EBIT per Share or its related term are showing as below:

ANHGY's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Mediclinic International's EBIT for the six months ended in Sep. 2022 was $152 Mil.

Mediclinic International EBIT per Share Historical Data

The historical data trend for Mediclinic International's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediclinic International EBIT per Share Chart

Mediclinic International Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

EBIT per Share

Get a 7-Day Free Trial

-0.79

-0.15

-0.33

0.31

0.49

Mediclinic International Semi-Annual Data
	Mar13	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22
EBIT per Share	Get a 7-Day Free Trial															0.09	0.22	0.23	0.27	0.21

Mediclinic International EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Mediclinic International's EBIT per Share for the fiscal year that ended in Mar. 2022 is calculated as

	EBIT per Share		(A: Mar. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	361.001	/	737.288
=	0.49

Mediclinic International's EBIT per Share for the quarter that ended in Sep. 2022 is calculated as

	EBIT per Share		(Q: Sep. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	151.755	/	737.537
=	0.21

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.48

Mediclinic International (OTCPK:ANHGY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Mediclinic International EBIT per Share Related Terms

Thank you for viewing the detailed overview of Mediclinic International's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mediclinic International (Mediclinic International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.mediclinic.com

Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.